TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Vistin Pharma AS
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
27,329
|
27,654
|
24,075 |
| Financial expenses |
1,071
|
769
|
2,207 |
| Earnings before taxes |
-345
|
3,537
|
3,584 |
| Total assets |
38,429
|
31,864
|
21,346 |
| Current assets |
14,986
|
12,341
|
7,532 |
| Current liabilities |
26,516
|
18,961
|
7,726 |
| Equity capital |
5,147
|
5,498
|
2,695 |
| - share capital |
9
|
10
|
3 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
13.4%
|
17.3%
|
12.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-1.3%
|
12.8%
|
14.9% |
| Return on assets (ROA) |
1.9%
|
13.5%
|
27.1% |
| Current ratio |
56.5%
|
65.1%
|
97.5% |
| Return on equity (ROE) |
-6.7%
|
64.3%
|
133.0% |
| Change turnover |
1,127
|
2,271
|
2,380 |
| Change turnover % |
4%
|
9%
|
11% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.